Safety and Efficacy of Oral Levosimendan in People With ALS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
Lancet Neurol 2021 Oct 01;20(10)821-831, M Cudkowicz, A Genge, N Maragakis, S Petri, L van den Berg, VV Aho, T Sarapohja, M Kuoppamäki, C Garratt, A Al-ChalabiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.